MedPath
HSA Approval

APO-FLUOXETINE CAPSULE 20 mg (Ivory/Green)

SIN09318P

APO-FLUOXETINE CAPSULE 20 mg (Ivory/Green)

APO-FLUOXETINE CAPSULE 20 mg (Ivory/Green)

May 2, 1997

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N06AB03

fluoxetine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

FLUOXETINE HCl EQV FLUOXETINE

20 mg

Fluoxetine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-FLUOXETINE CAPSULE 20 mg (Ivory/Green) - HSA Approval | MedPath